Channel Therapeutics Corporation (CHRO)
NYSEAMERICAN: CHRO · Real-Time Price · USD
1.680
+0.050 (3.07%)
At close: Feb 21, 2025, 4:00 PM
1.740
+0.060 (3.57%)
After-hours: Feb 21, 2025, 5:41 PM EST
Channel Therapeutics Market Cap
Channel Therapeutics has a market cap or net worth of $10.13 million as of February 21, 2025.
Market Cap
10.13M
Enterprise Value
11.16M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.68
Market Cap Chart
Since the IPO on February 16, 2024, Channel Therapeutics's market cap has decreased from $33.50M to $10.13M, a decrease of -69.77%. That is a compound annual growth rate of -69.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 10.13M | 162.09% |
| Dec 31, 2024 | 3.86M | -88.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |